Aardvark Therapeutics, Inc. (AARD)
1.32
+0.15
(+12.82%)
USD |
NASDAQ |
Nov 09, 11:47
Aardvark Therapeutics Market Cap : 28.89M for Nov. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 25.60M |
| November 05, 2026 | 24.29M |
| November 04, 2026 | 27.57M |
| November 03, 2026 | 26.92M |
| November 02, 2026 | 26.26M |
| October 30, 2026 | 29.76M |
| October 29, 2026 | 31.51M |
| October 28, 2026 | 33.05M |
| October 27, 2026 | 28.45M |
| October 26, 2026 | 23.63M |
| October 23, 2026 | 30.42M |
| October 22, 2026 | 86.44M |
| October 21, 2026 | 96.51M |
| October 20, 2026 | 85.35M |
| October 19, 2026 | 81.85M |
| October 16, 2026 | 82.72M |
| October 15, 2026 | 84.47M |
| October 14, 2026 | 84.91M |
| October 13, 2026 | 88.41M |
| October 12, 2026 | 97.38M |
| October 09, 2026 | 104.17M |
| October 08, 2026 | 103.07M |
| October 07, 2026 | 108.55M |
| October 06, 2026 | 110.30M |
| October 05, 2026 | 114.24M |
| Date | Value |
|---|---|
| October 02, 2026 | 109.20M |
| October 01, 2026 | 115.33M |
| September 30, 2026 | 115.33M |
| September 29, 2026 | 117.08M |
| September 28, 2026 | 115.33M |
| September 25, 2026 | 110.73M |
| September 24, 2026 | 121.46M |
| September 23, 2026 | 121.68M |
| September 22, 2026 | 125.83M |
| September 21, 2026 | 121.90M |
| September 18, 2026 | 117.74M |
| September 17, 2026 | 121.02M |
| September 16, 2026 | 112.70M |
| September 15, 2026 | 109.86M |
| September 14, 2026 | 121.46M |
| September 11, 2026 | 112.27M |
| September 10, 2026 | 109.64M |
| September 09, 2026 | 107.67M |
| September 08, 2026 | 116.64M |
| September 04, 2026 | 117.74M |
| September 03, 2026 | 125.40M |
| September 02, 2026 | 130.21M |
| September 01, 2026 | 129.55M |
| August 31, 2026 | 133.49M |
| August 28, 2026 | 126.71M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 673.13B |
| Bristol Myers Squibb Co. | 127.03B |
| ANI Pharmaceuticals, Inc. | 1.555B |
| Corcept Therapeutics, Inc. | 8.302B |
| Veru, Inc. | 37.34M |
Market Cap Related Metrics
| PEG Ratio | -0.0046 |
| Price to Book Value | 0.3862 |
| Price | 1.32 |
| Earnings Yield | -242.8% |
| PEGY Ratio | -0.0046 |